SEC Form 4 · accession 0001144204-18-033815
KIORA PHARMACEUTICALS INC · KPRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
Barbara Wirostko
Officer — Chief Medical Officer
Period of report
Jun 7, 2018
Accepted (ET)
Jun 11, 2018 · 8:37 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001372514
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jun 7, 2018 | A | 2,215 | $0.52 | A | 242,612 | D | |
| Common Stock | Jun 8, 2018 | A | 7,000 | $0.54 | A | 249,612 | D | |
| Common Stock | holding | — | — | — | 50,700 | I | By husband |
Table II — derivative securities
No Table II lines on this filing.